Propel Bio Management, LLC
Propel Bio Management, LLC reported 30 positions worth $188.6M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: PAGP (17.5%). Biggest move: reduce AQST ($35.9M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | PAGP | $33.0M | 17.47% | 1,272,360 | — | — | +1.8% | |
| ▸ 2 | ACHV | $31.3M | 16.57% | 3,864,148 | — | — | -21.9% | |
| ▸ 3 | DCTH | $9.7M | 5.12% | 604,664 | — | — | +24.4% | |
| ▸ 4 | COLL | $9.0M | 4.75% | 410,175 | — | — | — | |
| ▸ 5 | CORT | $8.7M | 4.60% | 75,274 | — | — | -39.9% | |
| ▸ 6 | AQST | $8.6M | 4.56% | 278,723 | — | — | -18.8% | |
| ▸ 7 | MIST | $8.2M | 4.34% | 9,449,727 | — | — | — | |
| ▸ 8 | PHAT | $8.1M | 4.28% | 1,105,913 | — | — | -17.0% | |
| ▸ 9 | CMPS | $6.8M | 3.62% | 549,186 | — | — | -33.5% | |
| ▸ 10 | OBIO | $5.6M | 2.96% | 896,701 | — | — | +14.5% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Propel Bio Management, LLC hold as of Q3 2026?
Propel Bio Management, LLC reported 30 positions worth $188.6M in its Q3 2026 13F filing. Largest positions: PAGP (17.5%), ACHV (16.6%), DCTH (5.1%), COLL (4.7%) and CORT (4.6%).
What did Propel Bio Management, LLC buy in Q3 2026?
New positions: COLL, CABA, PROK, IRD and SGP. Added to: MAZE, CRVS, MIST, PHAT and SABS.
What did Propel Bio Management, LLC sell in Q3 2026?
Reduced: AQST, CORT, DCTH, CLDX and ACHV (15 in all). Sold out entirely: ZVRA, EYPT, SLN and SGMT.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.